102 related articles for article (PubMed ID: 2245821)
1. Serum aldosterone response to metoclopramide in normal subjects and acromegalic patients.
Zacharieva S; Stoeva I; Matrozov P; Andonova K
Exp Clin Endocrinol; 1990 Aug; 95(3):331-8. PubMed ID: 2245821
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
[TBL] [Abstract][Full Text] [Related]
4. Effect of sodium depletion on the renin-angiotensin-aldosterone system and renal prostaglandins in acromegalic patients.
Zacharieva S; Andreeva M; Andonova K
Exp Clin Endocrinol; 1990 Nov; 96(2):213-8. PubMed ID: 2097166
[TBL] [Abstract][Full Text] [Related]
5. Dopamine control of aldosterone secretion in end-stage renal failure.
García-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL
Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288
[TBL] [Abstract][Full Text] [Related]
6. Plasma aldosterone response to metoclopramide in patients with Cushing's disease.
Zacharieva S; Stoeva I; Matrozov P; Andonova K
Exp Clin Endocrinol; 1993; 101(3):138-43. PubMed ID: 8223981
[TBL] [Abstract][Full Text] [Related]
7. Selectivity of metoclopramide for endocrine versus renal effects of dopamine in normal humans.
Blumberg AL; Dubb JW; Allison NL; Aldins Z; Ramey K; Stote RM
J Cardiovasc Pharmacol; 1988 Feb; 11(2):181-6. PubMed ID: 2452312
[TBL] [Abstract][Full Text] [Related]
8. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
[TBL] [Abstract][Full Text] [Related]
9. Evidence for increased endogenous dopaminergic inhibition of aldosterone secretion in prolactinoma.
Jungmann E; Schwedes U; Althoff PH; Rosak C; Schöffling K
Horm Metab Res; 1986 Oct; 18(10):704-5. PubMed ID: 3781476
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR
Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150
[TBL] [Abstract][Full Text] [Related]
11. Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism.
Mantero F; Opocher G; Boscaro M; Valpione E; Armanini D; Fallo F
Horm Metab Res; 1981 Aug; 13(8):464-7. PubMed ID: 7035323
[TBL] [Abstract][Full Text] [Related]
12. Endogenous dopaminergic inhibition of aldosterone and prolactin secretion is apparently not increased in primary aldosteronism.
Jungmann E; Althoff PH; Rosak C; Schwedes U; Schöffling K
Horm Metab Res; 1986 Feb; 18(2):138-40. PubMed ID: 3699687
[TBL] [Abstract][Full Text] [Related]
13. Sulpiride and thyrotrophin releasing hormone loading test in patients with acromegaly.
Zséli J; Földes J; Holló I; Kollin E; Horváth C; Gács G; Borvendég J
Acta Med Acad Sci Hung; 1980; 37(4):357-64. PubMed ID: 6785978
[TBL] [Abstract][Full Text] [Related]
14. [Lack of effect of aging on dopaminergic inhibition of aldosterone and prolactin increase].
Preis P; Luger A; Templ H; Tragl HK; Geyer G
Z Gerontol; 1985; 18(4):241-3. PubMed ID: 3901563
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
[TBL] [Abstract][Full Text] [Related]
16. Pressor and hormonal responses to intravenous injection of metoclopramide in normotensive and hypertensive patients.
Kawabe H; Suzuki H; Itaya Y; Saruta T
Jpn J Med; 1990; 29(2):174-9. PubMed ID: 2232366
[TBL] [Abstract][Full Text] [Related]
17. Enhanced response of plasma prolactin to metoclopramide during chronic converting enzyme inhibition.
Dupont AG; Van der Nipen P; Van Steirteghem AC; Vanhaelst L
Horm Metab Res; 1987 May; 19(5):212-5. PubMed ID: 3034757
[TBL] [Abstract][Full Text] [Related]
18. [Effect of captopril on the plasma aldosterone response to metoclopramide in normal subjects].
Zachariéva S; Koev D; Tcharaktchiev D; Moskov M; Andonova K
Ann Endocrinol (Paris); 1989; 50(3):233-6. PubMed ID: 2683976
[TBL] [Abstract][Full Text] [Related]
19. Effect of atrial natriuretic hormone on metoclopramide-induced stimulation of aldosterone.
Shenker Y; Meranda D; Clinkingbeard C; Lawrence D; Koch D
J Lab Clin Med; 1992 Aug; 120(2):297-304. PubMed ID: 1323636
[TBL] [Abstract][Full Text] [Related]
20. Enhanced response of plasma aldosterone to metoclopramide in essential hypertension.
Stern N; Sowers JR; Tuck M; Eshkol A; Lunenfeld B; Rosenthal T
J Hypertens; 1984 Apr; 2(2):209-14. PubMed ID: 6398336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
